Form 4 for PCVX Vaxcyte, Inc.
Accepted 2021-08-16 00:00:00 ET · period of report 2021-08-12 · accession 0001209191-21-051631 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-16 | 2021-08-12 | PCVX | Wright-Mitchell Jane | GC | M - OptEx | $2.03 | +10.0K | 13.1K | +320% | +$20.3K |
| D | 2021-08-16 | 2021-08-12 | PCVX | Wright-Mitchell Jane | GC | S - Sale+OE | $26.00 | -10.0K | 3,125 | -76% | -$260.0K |
| D | 2021-08-16 | 2021-08-12 | PCVX | Wright-Mitchell Jane | GC | M - OptEx | $0.00 | -10.0K | 190.0K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-12 | M | A | 10,000 | $2.03 | 13,125 | D | — | — | (F1) Includes 1,563 shares acquired under the Employment Stock Purchase Plan on May 17, 2021. |
| 2 | Common | Common Stock | 2021-08-12 | S | D | 10,000 | $26.00 | 3,125 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2021-08-12 | M | D | 10,000 | $0.00 | 189,968 | D | $2.03 · — to 2029-03-20 | 10,000 Common Stock | (F3) 1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter. |